Clinical Trials
Sponsor:
Sponsor Study ID:
Study Title:
Neuroendocrine Tumors Patient Reported Outcomes (NET PRO)
NCT Number:
NCT05064150
Phase:
N/A
Protocol Type:
Health Services Research
Age Group:
Adults
Disease Sites:
Lung, Other Digestive Organ, Pancreas
Study Objectives:
To describe the frequency of treatment regimens and examine their association with symptom burden and PROs and HRQol outcomes. Enroll a cohort of patients to collect HRQol and PROs data every 6 months, for 18 months (i.e.: baseline, 6, 12 and 18 month follow-up surveys). We will determine what combinations of therapy are being used, and the changes in symptoms, PROs and HRQoL associated with these different therapeutic choices.
Study Documents
(MUSC NetID required for document access)